Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32100146

Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Invest New Drugs
Publication date
2020 Oct
First author
Tian Z

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Tian Z
      type
      Author
    2. name
      Liu H
      type
      Author
    3. name
      Zhang F
      type
      Author
    4. name
      Li L
      type
      Author
    5. name
      Du X
      type
      Author
    6. name
      Li C
      type
      Author
    7. name
      Yang J
      type
      Author
    8. name
      Wang J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Tian Z
      type
      Author
    2. name
      Liu H
      type
      Author
    3. name
      Zhang F
      type
      Author
    4. name
      Li L
      type
      Author
    5. name
      Du X
      type
      Author
    6. name
      Li C
      type
      Author
    7. name
      Yang J
      type
      Author
    8. name
      Wang J
      type
      Author
    bibliography ids
    1. nci-bib-12833cd4c65e9d3bc8ea5fcc
    book metadata
    content sha256
    0e453c926d5a020793d6370a5e55bbd2d462b234cdfee9f7af5b945b9eec7108
    document type
    citation
    dois
    1. 10.1007/s10637-020-00912-7
    electronic publication date
    display
    2020 Feb 25
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:32100146
    immutable id
    pubmed:32100146@0e453c926d5a020793d6370a5e55bbd2d462b234cdfee9f7af5b945b9eec7108
    journal
    abbreviation
    Invest New Drugs
    issn electronic
    1573-0646
    issn print
    0167-6997
    issue
    5
    name
    Investigational new drugs
    nlm unique id
    8309330
    pages
    1559-1569
    volume
    38
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      32100146
      provenance
      batch id
      4c5003fbb78890e89ae1
      provider
      NCBI PubMed ESummary
      record sha256
      4ef61b96a1e6d1de1f1ca31973374f70bf72cc8f2b522bbaa36c0809bcb2aa9d
      response sha256
      890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
      retrieved at
      2026-09-09T23:47:48.270700+00:00
      publication date
      display
      2020 Oct
      precision
      month
      year
      2020
      publication types
      1. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/32100146/
      title
      Retrospective review of the activity and safety of apatinib and anlotinib in patients with advanced osteosarcoma and soft tissue sarcoma.

      Preserved source evidence · Not medical advice